Management of BU-HIV co-infection

Prise en charge de la co-infection BU-HIV

D. O'Brien , N. Ford , M. Vitoria , V. Christinet , E. Comte (1) , A. Calmy (2) , Y. Stienstra , S. Eholie , K. Asiedu

1 MSF - Médecins sans Frontières [Genève]
2 TransVIHMI - Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes

background Buruli Ulcer (BU)-HIV co-infection is an important emerging management challenge for BU disease. Limited by paucity of scientific studies, guidance for management of this co-infection has been lacking. methods Initiated by WHO, a panel of experts in BU and HIV management developed guidance principles for the management of BU-HIV co-infection based on review of available scientific evidence, current treatment experience, and global recommendations established for management of HIV infection and tuberculosis.

Domaines: Médecine humaine et pathologie

D. O'Brien, N. Ford, M. Vitoria, V. Christinet, E. Comte, et al.. Management of BU-HIV co-infection. Tropical Medicine and International Health, 2014, 19 (9), pp.1040-1047. ⟨10.1111/tmi.12342⟩. ⟨hal-02560118⟩